U.S. Banks Stock News

United Therapeutics reported positive TETON-2 study results for inhaled treprostinil in idiopathic pulmonary fibrosis (IPF). The data indicate a potential role for inhaled treprostinil in helping stabilize lung function for IPF patients. The FDA qualified the PROLIFIC Risk Score, a tool designed to identify IPF patients at higher risk of rapid progression and support more targeted clinical trials. United Therapeutics (NasdaqGS:UTHR) is drawing attention as it pairs clinical momentum with a...

Recent trading in Customers Bancorp (CUBI) has drawn attention after a one-month return of about a 7% decline, alongside an 8.6% gain over the past 3 months, prompting fresh questions about valuation and earnings power. See our latest analysis for Customers Bancorp. At a share price of $73.14, Customers Bancorp has seen short term momentum ease, with a 7 day share price return of a 6.6% decline, while the 1 year total shareholder return of 25.9% and 5 year total shareholder return of 172.8%...

For readers wondering whether Mattel, at around US$21.06, is offering fair value right now or if the market is mispricing the toy maker, this article walks through what the numbers actually say about the stock. The share price is US$21.06 after a 0.6% decline over the last 7 days, a 2.0% decline over 30 days, a 5.1% gain year to date and a 3.6% decline over the past year. These moves give mixed signals when you compare them with its 13.5% and 12.9% annualized returns over 3 and 5...

Investors are watching Bright Horizons Family Solutions (BFAM) ahead of Thursday afternoon’s earnings, after the child care provider exceeded analyst expectations on revenue and adjusted earnings last quarter. The company enters this release with forecasts for slower, but still solid, year-on-year growth. See our latest analysis for Bright Horizons Family Solutions. At a share price of $85.04, Bright Horizons has seen a 17.0% 1 month share price return decline and a 14.4% year to date share...

Sonos (SONO) is back in focus after a quarter where sales held around last year’s level, yet net income and earnings per share were much higher, helped by cost controls and product mix changes. See our latest analysis for Sonos. The earnings beat and recent buyback activity have coincided with a sharp shift in sentiment, with a 19.3% 7 day share price return and a 31.9% 1 year total shareholder return contrasting with weaker 3 and 5 year total shareholder returns. This suggests momentum has...

SMX (Security Matters) recently amended its equity line of credit, lifting the total capital commitment to US$250 million and extending its financing runway into 2028 to support brand protection, authentication, and track-and-trace initiatives. This enlarged and longer-term funding pool gives SMX more flexibility to run multiple platform deployments simultaneously and pursue longer-horizon enterprise and government projects without compressing implementation timelines. Given the strong 7-day...

Recently, Raymond James Financial was swept up in a sector-wide pullback after fintech firm Altruist launched an AI-powered planning tool that automates tax strategy design and document creation for financial advisers. The reaction highlights how quickly investor sentiment can shift when new technology raises questions about the durability of human-centered wealth-management models and fee structures. We’ll now explore how these AI disruption concerns intersect with Raymond James Financial’s...

Earlier in February 2026, Tidal Real Estate Partners secured US$371.5 million in financing from Madison Realty Capital and KSL Capital Partners for The Nashville EDITION Hotel & Residences, with Walker & Dunlop arranging the capital for the 28-story luxury hotel and residential tower. Around the same time, Walker & Dunlop was also recognized as Fannie Mae’s largest DUS lender for 2025 and a top Freddie Mac Optigo lender, underscoring its scale and influence in multifamily and commercial real...

If you are wondering whether BioMarin Pharmaceutical's current share price lines up with its underlying worth, this article will walk you through what the numbers say and how to interpret them. The stock closed at US$59.66 most recently, with returns of 3.6% over the last 7 days, 1.2% over 30 days, 0.4% year to date, and a 6.1% decline over 1 year, alongside larger declines of 45.1% over 3 years and 29.8% over 5 years. Recent attention on BioMarin has focused on its rare disease drug...

Ellington Financial plans to redeem all outstanding shares of its Series A Preferred Stock at the end of February 2026. Following the redemption, the Series A Preferred Stock will be delisted from the NYSE. The move will retire this layer of preferred capital and end related dividend payments to Series A holders. For common shareholders of NYSE:EFC, this preferred stock redemption sits alongside a share price of $12.85 and a mixed recent return profile. The stock is up 2.0% over the past...

Arhaus stock at a glance Arhaus (ARHS) has attracted investor attention after a mixed stretch, with a 15% gain over the past 3 months contrasting with weaker one year and year to date returns at recent prices near US$10.67. See our latest analysis for Arhaus. Recent trading has been choppy, with a 14.9% 90 day share price return contrasting with weaker year to date share price performance and a 14.8% decline in the 1 year total shareholder return. This suggests that momentum has faded after...

The Walt Disney Company ( NYSE:DIS ) announced strong profits, but the stock was stagnant. We did some digging, and we...

If you are wondering whether International Flavors & Fragrances is offering fair value right now, you are not alone. A closer look at its valuation can help frame your next move. The stock last closed at US$76.76, with recent returns of 9.1% over 7 days, 11.1% over 30 days, 12.8% year to date, but a 7.8% decline over 1 year, a 13.2% decline over 3 years and a 35.9% decline over 5 years. These mixed returns leave many investors looking to recent company updates and sector news to understand...

In recent months, IonQ has reported very large year-over-year revenue growth, pursued multi-billion-dollar acquisitions to build a vertically integrated quantum platform, and faced critical short-seller reports questioning its government-heavy revenue mix and aggressive expansion. Amid this tension between rapid expansion and concerns over cash burn and dilution, IonQ’s attempt to consolidate quantum hardware, networking, sensing, and security into one stack has become a central point of...

Cytokinetics recently announced recipients of its eighth annual Communications Grant Program, awarding two grants to hypertrophic cardiomyopathy patient advocacy groups to expand education and awareness, alongside confirming that MYQORZO (aficamten) is approved for symptomatic obstructive HCM and under marketing review in the European Union. This combination of regulatory progress for MYQORZO and direct support for HCM community outreach highlights how the company is tying its commercial...

First Financial Bankshares (NasdaqGS:FFIN) has appointed David Bailey as Chief Executive Officer and President. Long-time leader F. Scott Dueser is transitioning to the role of Executive Chairman after many years in top executive positions. The leadership changes mark a new chapter for the company while keeping both executives in key roles. First Financial Bankshares, a regional banking group, sits in a sector that continues to see pressure around funding costs, loan growth, and regulation...

Morgan Stanley recently issued a research report highlighting a strong recovery in China's tourism sector, underpinned by robust domestic demand and supportive government policies, and identified Atour Lifestyle Holdings as one of the key hotel operators positioned to benefit from this trend. This endorsement places Atour at the center of the anticipated expansion in tourism-related consumption, underscoring how its hotel-focused lifestyle brands could capture increased travel spending...

In early February 2026, Jacobs reported first-quarter 2026 results showing sales of US$3,293.28 million and net income of US$125.51 million, while also securing roles on major U.S. infrastructure and defense programs, including the Missile Defense Agency’s SHIELD contract and the Bolivar Roads Gate coastal protection project. These wins highlight Jacobs’ expanding footprint in high-complexity national security, coastal resilience, and rail mobility projects, reinforcing its position at the...

Solstice Advanced Materials reported fourth-quarter 2025 revenue of US$987 million and net income of US$41 million, alongside plans to boost uranium hexafluoride output at its Metropolis Works facility and initiate a quarterly dividend of US$0.075 per share. This combination of production expansion in a critical nuclear fuel input, supported by over US$2 billion in backlog and new dividend payments, reshapes how investors may view the company’s role in the nuclear energy supply chain. We’ll...

Woodward approved changes to its corporate governance, removing supermajority voting requirements. The company also eliminated cumulative voting rights for board elections. Alongside these changes, Woodward announced a 14% increase in its quarterly dividend. For investors watching NasdaqGS:WWD, these governance moves come as the stock trades at $391.53, with returns of 5.5% over the past week and 21.6% over the past month. Over longer periods, the shares show gains of 26.0% year to date,...

The Arrow Electronics, Inc. ( NYSE:ARW ) share price has done very well over the last month, posting an excellent gain...

Royalty Pharma plc's ( NASDAQ:RPRX ) dividend will be increasing from last year's payment of the same period to $0.235...

Following the solid earnings report from Phillips 66 ( NYSE:PSX ), the market responded by bidding up the stock price...

The Pulmonx Corporation ( NASDAQ:LUNG ) share price has fared very poorly over the last month, falling by a substantial...